GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CK Life Sciences International Holdings Inc (HKSE:00775) » Definitions » Tangible Book per Share

CK Life Sciences International Holdings (HKSE:00775) Tangible Book per Share : HK$0.06 (As of Dec. 2023)


View and export this data going back to 2002. Start your Free Trial

What is CK Life Sciences International Holdings Tangible Book per Share?

Tangible book value per share is calculated as the total tangible equity divided by Shares Outstanding (EOP). Total tangible equity is calculated as the Total Stockholders Equity minus Preferred Stock minus Intangible Assets. CK Life Sciences International Holdings's tangible book value per share for the quarter that ended in Dec. 2023 was HK$0.06.

Since intangibles such as goodwill cannot be sold when the company liquidates, tangible book value per share is considered more accurate in reflecting how much shareholders will receive when the company liquidates.


CK Life Sciences International Holdings Tangible Book per Share Historical Data

The historical data trend for CK Life Sciences International Holdings's Tangible Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CK Life Sciences International Holdings Tangible Book per Share Chart

CK Life Sciences International Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Tangible Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.06 0.10 0.09 0.06 0.06

CK Life Sciences International Holdings Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Tangible Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.09 0.07 0.06 0.06 0.06

Competitive Comparison of CK Life Sciences International Holdings's Tangible Book per Share

For the Biotechnology subindustry, CK Life Sciences International Holdings's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CK Life Sciences International Holdings's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CK Life Sciences International Holdings's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where CK Life Sciences International Holdings's Price-to-Tangible-Book falls into.



CK Life Sciences International Holdings Tangible Book per Share Calculation

CK Life Sciences International Holdings's Tangible Book Value Per Share for the fiscal year that ended in Dec. 2023 is calculated as

Tangible Book Value per Share=(Total Stockholders Equity-Preferred Stock-Intangible Assets)/Shares Outstanding (EOP)
=(4189.253-0-3572.711)/9611.07
=0.06

CK Life Sciences International Holdings's Tangible Book Value Per Share for the quarter that ended in Dec. 2023 is calculated as

Tangible Book Value per Share=(Total Stockholders Equity-Preferred Stock-Intangible Assets)/Shares Outstanding (EOP)
=(4189.253-0-3572.711)/9611.07
=0.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total equity is a balance sheet item and equal to total assets less total liabilities of the company. Since intangibles such as goodwill cannot be sold when the company liquidates, tangible book value per share is considered more accurate in reflecting how much shareholders will receive when the company liquidates.


CK Life Sciences International Holdings  (HKSE:00775) Tangible Book per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


CK Life Sciences International Holdings Tangible Book per Share Related Terms

Thank you for viewing the detailed overview of CK Life Sciences International Holdings's Tangible Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


CK Life Sciences International Holdings (HKSE:00775) Business Description

Traded in Other Exchanges
Address
2 Dai Fu Street, Tai Po Industrial Estate, Tai Po, Hong Kong, HKG
CK Life Sciences International Holdings Inc is a biotechnology company engaged in the research & development, commercialization, and sale of health and agricultural-related products. Products developed by CK Life Sciences are categorized into the areas of human health and environmental sustainability. The company operates three core businesses, including agriculture, nutraceutical, and pharmaceutical. Its overall product portfolio involves a presence that spans North America and the Asia Pacific. The company uses mergers and acquisitions when it identifies attractive market opportunities.

CK Life Sciences International Holdings (HKSE:00775) Headlines

No Headlines